Rare Case of Post-Dengue Mucormycosis Reported at Apollo Hospital in Delhi: Doctors

New Delhi: A “rare” case of mucormycosis was reported in a 49-year-old male patient at a major private hospital here after his recovery from dengue, doctors said Saturday.

The case reported at Apollo Hospital in South Delhi comes amid a large increase in the number of dengue cases in the national capital.

According to a civic report on vector-borne diseases released Monday, this season there have been nine deaths and a total of 2,708 cases of dengue as of November 6, which is the highest count since 2017 for the same period.

More than 1,170 cases were registered in the first week of November.

In a statement issued Saturday, Apollo Hospital said: “A team of hospital doctors has reported that a 49-year-old man is one of the rare cases of post-dengue mucormycosis.”

The patient had arrived at the hospital, complaining of a sudden loss of vision in one eye, 15 days after his recovery from the vector-borne disease.

During the second wave of the COVID-19 pandemic earlier this year, a large number of cases of the “black fungus” were reported across the country after coronavirus infection was detected in patients suffering from chronic diabetes.

Mucormycosis or “black fungus” is more common among people whose immunity has been lowered due to COVID-19, diabetes, kidney disease, liver or heart disorders, age-related problems, or those taking medications for autoimmune diseases such as rheumatoid arthritis.

Post-dengue mucormycosis is a new observation, and therefore patients with a recent history of dengue should stay up-to-date on their health and consult a health care expert immediately after noticing any new symptoms, Apollo Hospital doctors said. .

Dr. Suresh Singh Naruka, Senior Consultant (ENT), Indraprastha Apollo Hospitals, who leads the patient’s treatment, said: “A rare case of black fungus (mucormycosis) came into view when the patient arrived at the hospital, reporting a leak sudden vision in one eye after dengue fever.It is very rare to see mucormycosis as a post-recovery complication in a dengue patient, as this condition is usually seen in people who have a history of diabetes, immunity compromised and other infections “.

“It is a deadly infection caused by a group of fungi called mucor. This fungus invades healthy tissues in the nose, sinuses, eyes, and brain so quickly that any delay in diagnosis and treatment can lead to adverse complications. long term”. added.

Dengue is accompanied by a high fever, and therefore doctors believe that people may suspect that they have contracted COVID-19.

Dengue mosquito larvae breed in clear, standing water, while malaria mosquitoes thrive even in dirty water.

Dr. Atul Ahuja, senior consultant (otolaryngologist and head and neck surgery) at the hospital, said: “It is very important to diagnose and manage a case of rhinoorbital mucormycosis (affecting the nose and eyes) in a patient who has just had recover from dengue fever., since even after the best treatment, mucormycosis patients may lose their sight permanently and in a state of aggressive infection, removal of the eye becomes necessary to prevent further spread of the infection “.

Facility Registrar Dr. Nishant Rana said: “Before arriving at the hospital, the patient had an episode of nosebleed as a complication due to dengue 15 days before his recovery, in which he noticed a low platelet count without transfusion history. Mucormycosis in this case is a factor resulting from compromised immunity due to dengue. ”

This story has been published from a news agency feed with no changes to the text. Only the title has been changed.

Subscribe to Mint newsletters

* Please enter a valid email

* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint.
our application now !!

Source link

Leave a Comment